Last Updated: 23 September 2026 · Governance & Inspection Readiness · Safe
Lessons Learned · Safe · Medicines · 12 min read
Lessons Learned: A Medication Stock Failure, and a Registered Manager Prosecuted
A resident with epilepsy missed seven doses of his medication after the home ran out of stock, despite the alerts that should have prevented it. He died. The registered manager was prosecuted in person. Here is what the case asks every provider to check.
The stock system did its job. It sent the alert four times a day. The failure was in the step that turns a warning into an action.
Medication is one of the audit areas the Carevia Assurance Tools cover, with standards, evidence prompts and a single action plan built to catch exactly the gap this case turned on. Available through Carevia Pro+.
We have revisited this article because, at Carevia, we keep becoming aware of medication not being administered simply because it had run out of stock. It is a quiet failure that does not look dramatic in advance, and it recurs. When medicines are prescribed for conditions like epilepsy, stroke or blood clots, even one missed dose can have serious consequences, which is why a stock issue is never only an administrative one.
The CQC prosecution below shows where that failure can end, and how the accountability for it can land on a named individual. It is a hard case to read, and a necessary one, because the failures in it are ordinary ones that exist quietly in services that would never expect to make the news. This article summarises what happened, why it happened, and the checks it asks every registered manager and provider to run on their own service. It draws only on information the Care Quality Commission has published, and you can read the CQC press release in full on the CQC website.
What happened
At a nursing home in Halesowen, a resident living with epilepsy and dementia was prescribed 2.5ml of levetiracetam twice a day. Because he lacked the capacity to manage his own care, staff had to administer it as prescribed. His epilepsy was managed through a specific care plan, and uninterrupted medication was central to keeping him safe.
What the court heard
Records showed the resident was last given a dose on the evening of 5 June 2022. The home had not ensured there was enough of the medication in stock, and it ran out. He then missed seven doses between 6 and 9 June. The medication stock system sent the registered manager automated email alerts about the shortage four times a day. A prescription was not ordered in time, and he did not receive a further dose until 9 June. He suffered seizures, was admitted to hospital, and died. Epilepsy was recorded as a cause of death.
The Care Quality Commission prosecuted under Regulation 12, safe care and treatment, and Regulation 22(2)(a) of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. The penalty was a £2,000 fine, £5,500 towards CQC’s costs and a £190 victim surcharge, totalling £7,690. Our sympathies, like the regulator’s, are with the family of the person who died.
It was the registered manager who was prosecuted
This is the part of the case that every registered manager should sit with, because it is easy to read a story like this as a failure of an organisation and move on. The charge here was brought against the registered manager as an individual, and she pleaded guilty to failing to provide safe care and treatment.
CQC can and does prosecute individuals, not only providers, where a person has been exposed to avoidable harm. Regulation 12 places the duty to provide safe care and treatment squarely on the registered person, and the registered manager holds that duty in practice. A well-run corporate governance structure above you does not remove it, and a personal conviction is not something a provider can absorb on your behalf.
The point is not to frighten anyone. It is that the systems described in the rest of this article are not administrative housekeeping. They are the difference between a signal being acted on and a signal being missed, and the accountability for that difference can be personal. If you are a registered manager, the oversight of high-risk medication is your name on the duty, which is reason enough to know your own systems would not fail in the way this one did.
Five failures behind one death
Read as a single event, this looks like one missed reorder. Read as a system, it is five failures that lined up, and each of them is a check you can run on your own service this week.
Stock control. A high-risk medication ran out and was not reordered in time. For anti-epileptic drugs, insulin, anticoagulants and other medicines where a missed dose carries immediate risk, stock is not a monthly administrative task. It needs daily eyes and an immediate response when it runs low.
Care planning. An epilepsy care plan that does not spell out the urgency of uninterrupted medication, the consequences of a missed dose, and exactly who to contact when stock is low, leaves staff to improvise at the worst possible moment. The plan should make the escalation route impossible to miss.
Competence. Staff need to be trained and assessed as competent in the specific condition, not just in medication administration in general. Epilepsy has its own risks, and a completion certificate is not evidence that anyone understood them. This is the difference between training and competence.
Contingency. There was no clear emergency procedure for a depleted stock. Every service should be able to answer, in advance, what happens if a critical medicine is not available today, and every member of staff should know their part in it.
Oversight. The alerts arrived and were not escalated or resolved. A warning that is received but not acted on provides no protection at all, and it is worse than no warning, because it creates a record that the risk was known.
The alert was read, not acted on
The detail that stays with you is that the system worked. It monitored the stock, it noticed the shortage, and it raised the alarm four times a day. The technology did everything it was designed to do. What did not happen was the human step of turning that signal into a reorder.
The deeper point is that an alert is a backstop, not the plan. The stronger position is a stock system reliable enough that a critical medicine does not reach the point of running out at all: reorder levels set with real headroom, a named owner for high-risk stock, and a routine that reconciles what is prescribed against what is actually held. This is the governance the Carevia Assurance Tools are built to support. Using RAOF™, they put that system in place and keep testing that it holds, so adequate stock is maintained as a matter of routine rather than rescued by a warning once the margin is already gone.
No system, though, removes the need for people to act on what it flags, and that is the gap The Noticing Model™ bridges. The person leading the round or the shift is the one placed to notice a stock level falling and treat it as urgent before it becomes a missed dose, and that frontline judgement is what The Noticing Model™ is built to develop. The moment it matters most is the handover, where an observation like “we are low on his levetiracetam and nights will need to chase the reorder” either travels to the next shift or is lost. A Noticing Handover exists to carry exactly that kind of signal, so a critical detail does not depend on one person happening to remember.
A service could have every alert system available and still repeat this case, because no alert acts on itself. The question a manager has to be able to answer is not whether the warnings arrive. It is whether the stock system holds without them, who notices on the shift when it does not, who owns the response, and how you would know it had been done.
Governance that turns warnings into tracked actions
Carevia Pro gives you the toolkit, audit and policy library. Carevia Pro+ adds the Carevia Assurance Tools, the Inspection Readiness Dashboard and the RAOF™ Time Planner, so a signal becomes an owned action rather than a note nobody chased.
The medication assurance the Carevia Assurance Tools give you
Medication is one of the sixteen audit areas inside the Carevia Service Assurance Hub, part of the Carevia Assurance Tools. Rather than a folder of templates to complete, it is a structured set of standards that check whether medication practice is safe in the way this case needed it to be, and it is built around RAOF™ so that each standard produces real evidence rather than a signature.
The medication standards cover the ground where this case fell apart: stock control and timely reordering, MAR accuracy and the gap between a signature and a dose actually given, PRN protocols, covert administration, controlled drugs, and staff competency in the specific conditions people live with. Each standard carries Read, Ask, Observe and Feedforward prompts, so a stock-control check is not met by confirming a system exists. It is met by evidencing that alerts are seen, escalated and closed, which is precisely the step that was missing in Halesowen.
Every partial or unmet finding feeds one action plan with an owner, a due date and success criteria, and the loop is closed by re-testing rather than by marking a box complete. For providers running more than one service, the Carevia Provider Assurance Dashboard lets a nominated individual compare medication assurance across services, dip test any standard independently, and return a focused action to a service that has not evidenced it. That is oversight that would surface a stock-control weakness in one home before it became a prosecution.
A question for your next medication supervision
Case studies are only useful if they change what happens on a shift, so here is one practical way to bring this into your service. At your next medication-themed supervision, put a direct question to staff and treat their answer as a competency check rather than a conversation.
Ask your team
If a person’s prescribed medication was out of stock today, what would you do, who would you tell, and how would you know it had been sorted?
Listen for whether the escalation route is genuinely known, whether people can name who to contact, and whether anyone would assume someone else had dealt with it. The gap between the confident answers and the vague ones is the gap this case turned on, and finding it in supervision is far better than finding it during an inspection, or after harm. It is also worth asking what your team would notice sooner next time, because the earliest signal in this case was a stock figure that nobody treated as urgent.
Why this matters
Medication failures are a recurring cause of avoidable harm in adult social care, and they rarely look dramatic in advance. They look like a reorder that slipped, an alert that was glanced at, a care plan that did not quite spell out the urgency. Each seems minor on its own, which is exactly why they are dangerous together.
This case is a reminder that compliance is not paperwork, it is protection. When the systems that are meant to keep medication safe are present on paper but not working in practice, the people being supported carry the risk, and the provider and the registered manager carry the regulatory, legal and personal consequences. The strongest defence against all of it is the same thing that keeps people safe: knowing, not assuming, that your systems do what they are supposed to do.
Frequently asked questions
What happened in the Halesowen medication case?
A resident with epilepsy and dementia at a nursing home in Halesowen was prescribed levetiracetam twice a day. The home ran out of the medication and did not reorder it in time, despite an automated stock system alerting the registered manager four times a day. The resident missed seven doses between 6 and 9 June 2022, suffered seizures, was admitted to hospital and died, with epilepsy recorded as a cause of death. CQC prosecuted under Regulation 12 and Regulation 22(2)(a).
Can CQC prosecute a registered manager personally?
Yes. CQC can bring prosecutions against individuals as well as providers where a person has been exposed to avoidable harm. In this case the registered manager was prosecuted as an individual, pleaded guilty to failing to provide safe care and treatment, and was fined and ordered to pay costs and a victim surcharge. Regulation 12 places the duty for safe care and treatment on the registered person, and a corporate structure above a manager does not remove that personal duty.
What is Regulation 12?
Regulation 12 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 is the requirement to provide safe care and treatment. It covers assessing and mitigating risks to people’s health and safety, the safe management of medicines, ensuring staff have the competence to deliver care safely, and the safe use of equipment and premises. A failure in medicines management, as in this case, is a Regulation 12 matter.
Which medicines need this level of oversight?
Any medicine where a missed or delayed dose carries immediate risk needs closer oversight than routine stock. Anti-epileptic drugs are a clear example, as this case shows, and so are insulin, anticoagulants, medicines for Parkinson’s disease, and time-critical medicines generally. For these, stock control needs daily attention, a clear escalation route, and a contingency plan for when a medicine is not available, rather than a monthly administrative check.
How could this have been prevented?
By closing the gap between the alert and the action. The warning existed and arrived repeatedly, so the prevention was not better technology but a system that guaranteed someone owned the response, escalated it and confirmed it was done. Alongside that, a care plan that spelled out the urgency and the escalation route, staff assessed as competent in epilepsy specifically, and a contingency plan for depleted stock would each have given another chance to catch the failure before harm.
How do the Carevia Assurance Tools help with medication governance?
Medication is one of sixteen audit areas in the Carevia Service Assurance Hub. Its standards cover stock control and reordering, MAR accuracy, PRN protocols, covert administration, controlled drugs and staff competency, each with Read, Ask, Observe and Feedforward prompts so a check evidences that risks are managed in practice rather than that a system exists. Findings feed one action plan that is closed by re-testing, and the Provider Assurance Dashboard lets multi-service providers compare and dip test medication assurance across their homes. The Assurance Tools are available through Carevia Pro+ and Provider Licences.
Further reading
The Noticing Model™, developing the frontline judgement that catches a concern early, before it becomes an incident.
This article is for learning and improvement. It summarises information published by the Care Quality Commission and does not constitute legal advice or comment on any individual beyond what is already in the public record. It discusses a death and may be difficult to read. Always refer to current CQC guidance and use professional judgement in your own service.
Medication governance you can evidence, not just recordThe Carevia Assurance Tools turn audit findings into tracked, tested action. Included with Carevia Pro+.
